YuanMing Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7

- Investments
-
30
- Portfolio
-
15
- Exits
-
7

YuanMing Capital General Information
Description
YuanMing Capital is a healthcare based venture capital firm headquartered in Beijing, China. The firm prefers to invest in the therapeutics, medical devices, diagnostics and healthcare service sectors. Its regional preference is US and China.
Contact Information
Website
www.yuanmingcap.cn
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Room 1106, Tower B, China Waiwen Mansion
- No.89 North of West Third Ring Road, Haidian District
- Beijing, 100089
- China
YuanMing Capital Investments (30)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Maitong Medical | 14-Mar-2023 | Early Stage VC | 00.000 | Surgical Devices | Generating Revenue | |
00000000 | 02-Mar-2023 | 0000 00000 | 00.000 | Surgical Devices | Startup | |
00000000 0000 | 20-Feb-2023 | 00000 00000 | 00.000 | Therapeutic Devices | Generating Revenue | |
000000 0000000 | 03-Aug-2022 | 00000 00000 | 00.000 | Surgical Devices | Pre-Clinical Trials | |
0000 (0000000) | 01-Jan-2022 | 0000 00000 | 00.00 | Surgical Devices | Pre-Clinical Trials | |
000000000 000000 | 21-May-2021 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue/Not Profitable | |
000000 0000000000 | 01-Jan-2021 | 00000 00000 | Hospitals/Inpatient Services | Generating Revenue | ||
00000 000000000 | 18-Nov-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
CF PharmTech | 02-Jul-2020 | Later Stage VC | 000.00 | Drug Delivery | Generating Revenue | |
JW Therapeutics | 09-May-2019 | Early Stage VC | 00000 | Biotechnology | Generating Revenue/Not Profitable |
YuanMing Capital Exits (7)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
United-Imaging | 22-Aug-2022 | IPO | 00.000 |
000000000 000000 | 10-Dec-2021 | 000 | 000.00 |
00 000000000000 | 03-Nov-2020 | 000 | 00000 |
000000000 000000 | 28-Oct-2019 | 000 | 000.00 |
000000000 (0000000 | 14-Nov-2018 | 0000000000: 000000 | |
Edge Therapeutics | 01-Oct-2015 | IPO | 000.00 |
ContraFect | 12-Sep-2014 | IPO | 0000 |
YuanMing Capital Investments by Industry, Year, and Region
YuanMing Capital Team (7)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Fiona Gong | Managing Partner | Beijing, China | |||
Na Wu | Managing Partner | Beijing, China | |||
Ming Jiang Ph.D | Co-Founding Partner | Beijing, China | |||
Tina Yu Ph.D | Co-Founding Partner | 0 | Beijing, China | ||
Lawrence Tian Ph.D | Founding Partner | 0 | 0 | Beijing, China |
YuanMing Capital Co-Investors (32)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 1 |
![]() |
![]() |
||
China International Capital Corporation | 0 |
![]() |
![]() |
||
General Atlantic | 0 | 0 |
![]() |
![]() |
|
Golden Partners Capital | 0 |
![]() |
![]() |
||
Temasek Holdings | 0 |
![]() |
![]() |